Zhong Luo[Author] - Search Results

Year	Number of Results
2003	1
2008	1
2009	1
2010	2
2011	5
2012	9
2013	12
2014	10
2015	10
2016	11
2017	5
2018	11
2019	14
2020	22
2021	19
2022	28
2023	26
2024	7

1

Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells.

Yao X, Li W, Fang D, Xiao C, Wu X, Li M, Luo Z. Yao X, et al. Among authors: luo z. Adv Sci (Weinh). 2021 Nov;8(22):e2100997. doi: 10.1002/advs.202100997. Epub 2021 Oct 10. Adv Sci (Weinh). 2021. PMID: 34632727 Free PMC article. Review.

2

HCAR1/MCT1 Regulates Tumor Ferroptosis through the Lactate-Mediated AMPK-SCD1 Activity and Its Therapeutic Implications.

Zhao Y, Li M, Yao X, Fei Y, Lin Z, Li Z, Cai K, Zhao Y, Luo Z. Zhao Y, et al. Among authors: luo z. Cell Rep. 2020 Dec 8;33(10):108487. doi: 10.1016/j.celrep.2020.108487. Cell Rep. 2020. PMID: 33296645 Free article.

3

A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses.

Wang X, Liu Y, Xue C, Hu Y, Zhao Y, Cai K, Li M, Luo Z. Wang X, et al. Among authors: luo z. Nat Commun. 2022 Sep 28;13(1):5685. doi: 10.1038/s41467-022-33301-0. Nat Commun. 2022. PMID: 36167857 Free PMC article.

4

Multienzyme-like Reactivity Cooperatively Impairs Glutathione Peroxidase 4 and Ferroptosis Suppressor Protein 1 Pathways in Triple-Negative Breast Cancer for Sensitized Ferroptosis Therapy.

Li K, Lin C, Li M, Xu K, He Y, Mao Y, Lu L, Geng W, Li X, Luo Z, Cai K. Li K, et al. Among authors: luo z. ACS Nano. 2022 Feb 22;16(2):2381-2398. doi: 10.1021/acsnano.1c08664. Epub 2022 Jan 18. ACS Nano. 2022. PMID: 35041395

5

Oxygen Self-Generating Nanoreactor Mediated Ferroptosis Activation and Immunotherapy in Triple-Negative Breast Cancer.

Li K, Xu K, He Y, Yang Y, Tan M, Mao Y, Zou Y, Feng Q, Luo Z, Cai K. Li K, et al. Among authors: luo z. ACS Nano. 2023 Mar 14;17(5):4667-4687. doi: 10.1021/acsnano.2c10893. Epub 2023 Mar 2. ACS Nano. 2023. PMID: 36861638

6

Biomaterial-enabled therapeutic modulation of cGAS-STING signaling for enhancing antitumor immunity.

Liu Y, Fei Y, Wang X, Yang B, Li M, Luo Z. Liu Y, et al. Among authors: luo z. Mol Ther. 2023 Jul 5;31(7):1938-1959. doi: 10.1016/j.ymthe.2023.03.026. Epub 2023 Mar 31. Mol Ther. 2023. PMID: 37002605 Review.

7

Functionally Tailored Metal-Organic Framework Coatings for Mediating Ti Implant Osseointegration.

Zhang Y, Cheng Z, Liu Z, Shen X, Cai C, Li M, Luo Z. Zhang Y, et al. Among authors: luo z. Adv Sci (Weinh). 2023 Oct;10(29):e2303958. doi: 10.1002/advs.202303958. Epub 2023 Sep 13. Adv Sci (Weinh). 2023. PMID: 37705110 Free PMC article. Review.

8

Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer.

Ren X, Cheng Z, He J, Yao X, Liu Y, Cai K, Li M, Hu Y, Luo Z. Ren X, et al. Among authors: luo z. Nat Commun. 2023 Nov 2;14(1):7021. doi: 10.1038/s41467-023-42883-2. Nat Commun. 2023. PMID: 37919262 Free PMC article.

9

Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape.

Yang H, Yao X, Liu Y, Shen X, Li M, Luo Z. Yang H, et al. Among authors: luo z. ACS Nano. 2023 Aug 22;17(16):15328-15353. doi: 10.1021/acsnano.3c04632. Epub 2023 Aug 13. ACS Nano. 2023. PMID: 37573530 Review.

10

Autophagy-Dependent Ferroptosis as a Therapeutic Target in Cancer.

Liu L, Li L, Li M, Luo Z. Liu L, et al. Among authors: luo z. ChemMedChem. 2021 Oct 6;16(19):2942-2950. doi: 10.1002/cmdc.202100334. Epub 2021 Jul 19. ChemMedChem. 2021. PMID: 34110079 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

174 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Results by year